We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
AUM
$852M
AUM Growth
+$34.2M
Cap. Flow
-$2.21M
Cap. Flow %
-0.26%
Top 10 Hldgs %
41.05%
Holding
1,206
New
80
Increased
123
Reduced
188
Closed
61

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$4.54M
2
KDP icon
Keurig Dr Pepper
KDP
+$3.78M
3
MON
Monsanto Co
MON
+$1.55M
4
VZ icon
Verizon
VZ
+$1.04M
5
PM icon
Philip Morris
PM
+$809K

Sector Composition

Rank Sector Weight
1 Financials 22.14%
2 Consumer Discretionary 16.55%
3 Technology 16.32%
4 Communication Services 12.04%
5 Healthcare 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVNS
751
DELISTED
Avanos Medical
AVNS
$14.7K ﹤0.01%
256
AKAM icon
752
Akamai
AKAM
$15.4B
$14.6K ﹤0.01%
+200
New +$15K
WMB icon
753
Williams Companies
WMB
$90.2B
$14.6K ﹤0.01%
540
XLF icon
754
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
$14.6K ﹤0.01%
550
SGDJ icon
755
Sprott Junior Gold Miners ETF
SGDJ
$372M
$14.6K ﹤0.01%
500
NE
756
DELISTED
Noble Corporation
NE
$14.5K ﹤0.01%
2,294
STE icon
757
Steris
STE
$22.8B
$14.5K ﹤0.01%
+138
New +$13.9K
VRTX icon
758
Vertex Pharmaceuticals
VRTX
$137B
$14.4K ﹤0.01%
85
FITB
759
Fifth Third Bancorp
FITB
$49.5B
$14.3K ﹤0.01%
+500
New +$15.9K
SGMO
760
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$14.2K ﹤0.01%
1,000
IYF icon
761
iShares US Financials ETF
IYF
$4.31B
$14.1K ﹤0.01%
240
PVG
762
DELISTED
PRETIUM RESOURCES INC.
PVG
$14K ﹤0.01%
1,910
SHYG icon
763
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.68B
$14K ﹤0.01%
300
REG icon
764
Regency Centers
REG
$13.8B
$14K ﹤0.01%
225
WRN
765
Western Copper and Gold
WRN
$570M
$13.9K ﹤0.01%
16,600
VIPS icon
766
Vipshop
VIPS
$6.42B
$13.9K ﹤0.01%
1,285
FSB
767
DELISTED
Franklin Financial Network, Inc.
FSB
$13.9K ﹤0.01%
370
AOI
768
DELISTED
Alliance One International
AOI
$13.9K ﹤0.01%
877
TVRD
769
Tvardi Therapeutics
TVRD
$24.3M
$13.8K ﹤0.01%
20
GPRO icon
770
GoPro
GPRO
$111M
$13.7K ﹤0.01%
2,135
DNOW icon
771
DNOW Inc
DNOW
$2.88B
$13.7K ﹤0.01%
1,031
TTM
772
DELISTED
Tata Motors Limited
TTM
$13.7K ﹤0.01%
700
-345
-33% -$8.15K
TCX icon
773
Tucows
TCX
$113M
$13.6K ﹤0.01%
225
DFJ icon
774
WisdomTree Japan SmallCap Dividend Fund
DFJ
$405M
$13.6K ﹤0.01%
177
JOYY
775
JOYY Inc
JOYY
$3.65B
$13.6K ﹤0.01%
+135
New +$14.1K

Similar funds

RBC Europe's Q2 2018 Portfolio in Review

As of Q2 2018, RBC Europe held 1,206 positions worth $852M, up 4.2% from $817M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

RBC Europe's Q2 2018 filing shows 80 new, 123 increased, 188 reduced and 61 closed positions. Its largest new stake was Pluralsight, Inc. Class A Common Stock: 12,370 shares worth $302K. The largest sale was Celgene Corp, an estimated $4.54M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Technology.

  • RBC Europe's largest Q2 2018 buy was Pluralsight, Inc. Class A Common Stock: 12,370 shares worth $302K.
  • RBC Europe added most to Berkshire Hathaway Class B in Q2 2018, an estimated $4.02M increase.
  • RBC Europe's biggest Q2 2018 reduction was Celgene Corp, cutting an estimated $4.54M.
  • RBC Europe fully exited Monsanto Co in Q2 2018, selling an estimated $1.55M.
  • RBC Europe's ten largest holdings make up 41% of its $852M portfolio in Q2 2018.
  • RBC Europe opened 80 new positions and closed 61 in Q2 2018.
  • RBC Europe's portfolio value rose 4.2% quarter-over-quarter to $852M.

Based on RBC Europe's 13F filing for Q2 2018, filed 9 Nov 2023.